Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carteolol: preliminary study on ocular pressure-reducing action.

G Gorgone, F Spina, L Amantia

    Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diagnostic accuracy of right pulmonary vein-to-pulmonary artery ratio to identify congestive heart failure in dogs affected by myxomatous mitral valve disease.

    Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2026
    Same author

    Multi-platform satellite-derived products during the 2025 Etna eruption.

    Scientific data·2025
    Same author

    Decapitation of an agricultural worker by a combine harvester: a case report.

    La Clinica terapeutica·2023
    Same author

    Sudden death after fatal percussion of the cervical neurovascular bundle.

    La Clinica terapeutica·2023
    Same author

    3D printing and 3D bioprinting technology in medicine: ethical and legal issues.

    La Clinica terapeutica·2023
    Same author

    First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin.

    Annals of oncology : official journal of the European Society for Medical Oncology·2022

    This study shows that carteolol, a new beta-blocking agent, effectively lowers eye pressure in patients with open-angle glaucoma. The treatment demonstrated significant efficacy without notable adverse effects.

    Area of Science:

    • Ophthalmology
    • Pharmacology

    Background:

    • Open-angle glaucoma is a leading cause of irreversible blindness.
    • Effective pressure reduction is crucial for managing glaucoma progression.

    Purpose of the Study:

    • To evaluate the efficacy and safety of a novel beta-blocking agent, carteolol.
    • To assess the pressure-reducing capabilities of carteolol in open-angle glaucoma patients.

    Main Methods:

    • Clinical study involving subjects with open-angle glaucoma.
    • Administration of carteolol as a treatment.
    • Monitoring of intraocular pressure and side effects.

    Main Results:

    • Carteolol demonstrated efficacy in reducing intraocular pressure in all treated subjects.

    Related Experiment Videos

  • No significant or noteworthy side effects were observed during the study period.

    • Conclusions:

    • Carteolol is an effective and well-tolerated medication for managing open-angle glaucoma.
    • The new beta-blocker presents a promising therapeutic option for glaucoma patients.